HERPLEX Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Herplex, and when can generic versions of Herplex launch?
Herplex is a drug marketed by Allergan and is included in one NDA.
The generic ingredient in HERPLEX is idoxuridine. There are two drug master file entries for this compound. Additional details are available on the idoxuridine profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for HERPLEX?
- What are the global sales for HERPLEX?
- What is Average Wholesale Price for HERPLEX?
Summary for HERPLEX
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 86 |
| Patent Applications: | 3,929 |
| DailyMed Link: | HERPLEX at DailyMed |
US Patents and Regulatory Information for HERPLEX
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Allergan | HERPLEX | idoxuridine | SOLUTION/DROPS;OPHTHALMIC | 013935-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
